355 related articles for article (PubMed ID: 29316808)
1. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
2. Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.
Al-Husseini MJ; Saad AM; Turk T; Tabash MA; Abdel-Rahman O
J Gastrointest Cancer; 2019 Dec; 50(4):794-800. PubMed ID: 30105523
[TBL] [Abstract][Full Text] [Related]
3. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
Njei B; McCarty TR; Birk JW
J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
[TBL] [Abstract][Full Text] [Related]
4. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
5. Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database.
Gharzai L; Verma V; Denniston KA; Bhirud AR; Bennion NR; Lin C
PLoS One; 2016; 11(7):e0158916. PubMed ID: 27428362
[TBL] [Abstract][Full Text] [Related]
6. Cervical esophageal cancer: a population-based study.
Grass GD; Cooper SL; Armeson K; Garrett-Mayer E; Sharma A
Head Neck; 2015 Jun; 37(6):808-14. PubMed ID: 24616217
[TBL] [Abstract][Full Text] [Related]
7. Does a history of malignancy impact the survival of a subsequent endometrial adenocarcinoma? Should clinical trials eligibility criteria be revisited?
Mohamed HH; Ibrahim Sokkar M; Afifi AM; Saad AM; Albarouki S; Al-Husseini MJ
J Obstet Gynaecol; 2020 Feb; 40(2):233-239. PubMed ID: 31352852
[TBL] [Abstract][Full Text] [Related]
8. Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer.
Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O
Future Oncol; 2018 Jan; 14(1):65-75. PubMed ID: 29235888
[TBL] [Abstract][Full Text] [Related]
9. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
Shin JY; Yoon JK; Marwaha G
Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis.
Dubecz A; Gall I; Solymosi N; Schweigert M; Peters JH; Feith M; Stein HJ
J Thorac Oncol; 2012 Feb; 7(2):443-7. PubMed ID: 22173700
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
[TBL] [Abstract][Full Text] [Related]
12. A Population-Based Examination of the Surgical Outcomes for Patients with Esophageal Sarcoma.
Wu GX; Ituarte PH; Paz IB; Kim J; Raz DJ; Kim JY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1310-7. PubMed ID: 26310279
[TBL] [Abstract][Full Text] [Related]
13. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
14. Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma.
Zhang G; Wu B; Wang X; Li J
Medicine (Baltimore); 2019 Sep; 98(36):e17083. PubMed ID: 31490413
[TBL] [Abstract][Full Text] [Related]
15. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
16. Association of esophageal adenocarcinoma with other subsequent primary cancers.
Das A; Thomas S; Zablotska LB; Neugut AI; Chak A
J Clin Gastroenterol; 2006; 40(5):405-11. PubMed ID: 16721221
[TBL] [Abstract][Full Text] [Related]
17. Impact of postoperative radiation after esophagectomy for esophageal cancer.
Schreiber D; Rineer J; Vongtama D; Wortham A; Han P; Schwartz D; Choi K; Rotman M
J Thorac Oncol; 2010 Feb; 5(2):244-50. PubMed ID: 20009774
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
19. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.
Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M
Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959
[TBL] [Abstract][Full Text] [Related]
20. Small cell carcinoma of the esophagus: a SEER database analysis.
Kukar M; Groman A; Malhotra U; Warren GW; Bogner P; Nwogu CE; Demmy TL; Yendamuri S
Ann Surg Oncol; 2013 Dec; 20(13):4239-44. PubMed ID: 23943025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
